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Abstract: Diabetic kidney disease is a major complication in diabetes mellitus, and the most common
reason for end-stage renal disease. Patients suffering from diabetes mellitus encounter glomerular
damage by basement membrane thickening, and develop albuminuria. Subsequently, albuminuria can
deteriorate the tubular function and impair the renal outcome. The impact of diabetic stress conditions
on the metabolome was investigated by untargeted gas chromatography–mass spectrometry (GC-MS)
analyses. The results were validated by qPCR analyses. In total, four cell lines were tested, representing
the glomerulus, proximal nephron tubule, and collecting duct. Both murine and human cell lines
were used. In podocytes, proximal tubular and collecting duct cells, high glucose concentrations
led to global metabolic alterations in amino acid metabolism and the polyol pathway. Albumin
overload led to the further activation of the latter pathway in human proximal tubular cells. In the
proximal tubular cells, aldo-keto reductase was concordantly increased by glucose, and partially
increased by albumin overload. Here, the combinatorial impact of two stressful agents in diabetes on
the metabolome of kidney cells was investigated, revealing effects of glucose and albumin on polyol
metabolism in human proximal tubular cells. This study shows the importance of including highly
concentrated albumin in in vitro studies for mimicking diabetic kidney disease.
Keywords: diabetic kidney disease; metabolomics; GC-MS; diabetic nephropathy; albumin stress;
tubule; podocyte; diabetic complication; polyol metabolism
1. Introduction
During the last decades, diabetes mellitus has become a major socio-economic burden for health
care systems and societies all over the world. In 2017, 425 million people were affected by diabetes
worldwide, and the prevalence of the disease in adults rose to 12.2% in Germany [1]. The growing
incidence and prevalence have led to immense challenges for clinicians and caretakers. Diabetes results
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in tremendous suffering, reduced quality of life, and significant co-morbidities like cardiovascular
disease, stroke, retinopathy, peripheral neuropathy, and peripheral artery occlusive disease [2,3].
In particular, the kidney is susceptible to the microvascular complications of diabetes, and diabetic
kidney disease (DKD) represents a major cause of morbidity and mortality in diabetic patients [4].
DKD occurs in 20%–40% of type 2 diabetic patients, and induces a progressive decline of the glomerular
filtration rate (GFR), leading to end-stage renal disease [5]. It is the most common cause of renal
replacement therapy, accounting for over 40% of new cases [6]. The leading clinical manifestations of
diabetic nephropathy are progressive chronic kidney disease and albuminuria [7].
Diabetes mellitus is a complex metabolic disease. In DKD, specific alterations of the metabolic
pathways occur, like an upregulation of glycolysis, tricarboxylic acid cycle (TCA cycle), and
β-oxidation [8]. Concurrently, several studies showed mitochondrial dysfunction and reduced
mitochondrial biogenesis [8,9]. It has long been known that the polyol pathway plays an important
role in the pathogenesis of diabetic kidney disease [10]. In conditions of hyperglycemia, when glucose
phosphorylation by hexokinase is saturated, up to 30% of the glucose turnover can be metabolized
in the polyol pathway [11,12]. Aldo-keto reductase (AR) is the rate-limiting enzyme of the polyol
pathway, and catalyzes the reduction of glucose to sorbitol [12]. Transgenic mice overexpressing AR
showed an aggravation of kidney complications under diabetic conditions [13]. The second reaction
of the polyol pathway is catalyzed by sorbitol dehydrogenase, which converts sorbitol to fructose.
This pathway contributes to the redox imbalance in diabetes, which, in turn, can lead to oxidative
stress [14–16]. Interestingly, the accumulation of fructose can elicit tubulointerstitial inflammation and
renal injury [17].
In a recently published metabolomics study, Bernardo-Bermejo et al. analyzed glucose-induced
changes of exo- and endo-metabolome in a human proximal tubular cell line (HK-2 cells), using an
untargeted metabolomic strategy based on liquid chromatography–mass spectrometry [18]. HK-2
cells were exposed to different glucose concentrations and were analyzed by the application of two
chromatographic approaches (hydrophilic interaction and reversed-phase liquid chromatography).
The group could detect several altered metabolic pathways, including nitrogenous bases metabolism,
amino acid metabolism, and polyol metabolism. Showing elevated concentrations of sorbitol, they could
find evidence for the hyperglycemia-induced activation of the polyol pathway.
Renal proximal tubule epithelial cells/telomerase reverse transcriptase 1 (RPTEC/TERT1) cells are
a human proximal tubular cell line widely used for studies of the proximal tubule [19,20]. After the
immortalization of primary human proximal cells with hTERT, the RPTEC/TERT1 cells maintain many
characteristics of proximal tubular cells in vivo, remain highly differentiated, and form tight epithelial
layers [19]. The expression of specific transporters like the cubilin and megalin (LRP2) receptors, which
mediate the endocytosis of albumin [21], suggests that this cell line is highly suitable for studying the
implications of diabetic kidney disease and albuminuria.
Previously, we described the direct conversion of fibroblasts to induced renal epithelial tubular
cells (iRECs) by lentiviral transduction of the four transcription factors Pax8, Hnf1b, Hnf4a, and
Emx2 [22]. iRECs represent a tubular cell line and bear a substantial similarity to primary tubular
cells, as shown by transcriptional profiling and CellNet [23]-based characterization [22]. Analogously
to the RPTEC/TERT1 cells, iRECs express proximal-tubule specific transporters like Oct2 (organic
cation transporter-2; Slc22a2) and the apolipoprotein-receptor megalin (Lrp2). Moreover, the detection
of microvilli and evidence for endocytotic uptake of albumin emphasizes the applicability of iRECs
for studies of the proximal nephron tubule. In a recent study [24], we analyzed the metabolome of
iRECs by gas chromatography–mass spectrometry (GC-MS), showing a high resemblance to mouse
kidneys. Interestingly, treatment of iRECs with the nephrotoxic chemotherapeutic drug cisplatin
led to characteristic changes of the endo- and exo-metabolome [24], which can also be detected in
in vivo studies.
The mIMCD-3 cell line represents the murine inner medullary collecting duct, and was
immortalized by SV40. mIMCD-3 cells display typical characteristics of epithelial cells of the inner
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medullary collecting duct, such as the expression of the amiloride-sensitive epithelial sodium channel
or the N-methyl-D-aspartate receptor [25,26].
In 2002, the lab of Peter Mundel developed a human podocyte cell line, which was immortalized by
a temperature sensitive SV40-T gene. At 33 ◦C, these podocytes proliferate in an undifferentiated state
under the control of SV40, but at 37 ◦C, when the expression of SV40 is terminated, they differentiate
and express specific podocyte markers such as nephrin, podocin, synaptopodin, or p57 [27]. This cell
line represents a commonly- and widely-used in vitro system to study specific questions concerning
podocytes and the glomerulus.
Although the tubular system and distal parts of the nephron are increasingly in the focus of DKD
research, the impact of highly concentrated albumin on the tubular epithelial cell metabolism has not
been analyzed in in vitro studies yet. We speculated that this stressful factor, in combination with
elevated glucose levels, affects the renal cell metabolism. In this study, we report for the first time
an untargeted metabolomics approach to reveal the effects of albumin and glucose on different renal
cell lines.
2. Materials and Methods
2.1. Cell Culture
The human immortalized podocytes were kindly provided by Moin Saleem (Bristol, U.K.) and were
cultured as reported [27]. In brief, the cells were cultured in RPMI 1640, including 10% fetal calf serum
(FCS), penicillin/streptomycin, and insulin/transferrin/selenite (Roche), as well as pyruvic acid, minimal
essential medium, and HEPES buffer (Life technologies). After 10–14 days at 37 ◦C, differentiation was
induced. Afterwards, the cells were incubated with the indicated glucose concentration for 24 h.
Mouse embryonic fibroblasts (MEFs) were reprogrammed to iRECs as previously described [22].
In short, Ksp-Cre (kidney-specific protein; Cdh16) reporter MEFs, containing a Tomato/GFP cassette,
were obtained from the limbs of E13.5 mouse embryos and kept in MEF medium (MEFM), containing
Dulbeccos’s modified Eagle’s medium (DMEM, Gibco™), 2 mM L-glutamine, penicillin/streptomycin,
and 10% fetal bovine serum (FBS). At confluency, the cells were split 1:4 using 0.25% trypsin-EDTA,
and transduced with four lentiviruses, each containing one of the murine transcription factors mPax8,
mHnf1b, mEmx2, and mHnf4a. The transcription factors were cloned into the pWPXLd lentiviral
vector (Addgene no. 12258). The concentrated lentiviruses were diluted 1:100 to 1:1000 in MEFM
containing 8 µg mL−1 polybrene (sc-134220), and were transduced for 12 h for seven consecutive days.
In the MEFs, which were efficiently reprogrammed to iRECs, the expression of a Cre recombinase under
the control of the Ksp promoter leads to a change in fluorescence from Tomato to GFP. Consecutively,
GFP-positive iRECs were sorted 14 days after the last lentiviral transduction, using a BD FACSAria™
Fusion flow cytometer (Becton Dickinson).
RPTEC/TERT1 cells (ATCC® CRL-4031™) were purchased from ATCC, Manassas, VA, USA.
These cells represent an immortalized cell line after the retroviral transduction of pLXSN-hTERT.
They were grown in Renal Epithelial Cell Growth Medium (REGM™; Lonza, CC-3190), containing
REBM™ Basal Medium (CC-3191) and REGM™ SingleQuots™ supplements (CC-4127).
The iRECs and mIMCD-3 cells (ATCC® CRL-2123™, ATCC, Manassas, VA, USA) were
cryoconserved in freezing medium, containing 10% DMSO, 40% FBS, and 50% MEFM, and stored
in liquid nitrogen. RPTEC/TERT1 cells were cryoconserved in freezing medium containing 50%
DMEM/F12 (Gibco™). After thawing, all of the cell lines were seeded with an initial density of 1 · 106
cells per 10 cm dish, and were grown until confluency.
For metabolomic and transcriptional analyses, the cell lines were cultivated in the following
four different media conditions for 48 h: high glucose (HG), high glucose plus albumin (HG+Alb),
normal glucose (NG), and normal glucose plus albumin (NG+Alb). The following media were
applied, containing two different glucose concentrations, namely: DMEM high glucose (4.5 g L−1
glucose (24.98 mM, 450 mg dL−1), Gibco™ 41966029) and DMEM low (Normal) glucose (1.0 g L−1
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glucose (5.55 mM, 100 mg dL−1), Gibco™ 31885023). For albumin overload, sterile filtered bovine
serum albumin was added to a final concentration of 10 mg mL−1 (Bovine Serum Albumin (BSA)
Fraction V, CAS 9048-46-8, Biomol). Penicillin/streptomycin and FBS (10% final concentration FBS)
were added to each media composition. For the metabolomic analysis, four replicates per media
condition were cultivated. After harvesting, the cells were directly processed for metabolite extraction
or RNA extraction.
2.2. Quantitative RT-PCR
The total RNA was extracted with the QIAzol Lysis Reagent (Qiagen no. 79306), and was
isolated using the RNeasy Plus Universal Mini Kit (Qiagen no. 73404). The QuantiTect Reverse
Transcription Kit (Qiagen no. 205311) was applied to reversely transcribe 1 µg of total RNA to
cDNA, according to the manufacturer’s instructions. Quantitative PCR was performed on a Roche
LightCycler® 480 instrument using 10 ng of cDNA, gene-specific primers, and Takyon™ SYBR® Master
Mix (Takyon™ No Rox SYBR® MasterMix dTTP Blue, Eurogentec, UF-NSMT-B0701). The primers
are listed in Supplementary Table S1. For the normalization of threshold cycle (CT) values, primers
aligning the following housekeeping genes were used: Tbp (mouse) and glyceraldehyde-3-phosphate
dehydrogenase (GAPDH; human). The qPCR data were analyzed applying the comparative CT
method [28]. Normalized values were statistically compared using an unpaired Student’s t-test.
2.3. Untargeted Metabolomics
Untargeted metabolomics was conducted as previously reported [24]. In brief, the cells were
washed with 0.9% NaCl (Sigma Aldrich) and harvested with ice-cold methanol:water 9:1 (v:v) by
scraping. After mechanical lysis and centrifugation by a Precellys24 (Bertin), the metabolite containing
supernatant was evaporated. After derivatization with methoxyamine hydrochloride (Supelco) in
pyridine (Roth) and N-methyl-N-(trimethylsilyl)trifluoroacetamide (Sigma Aldrich), the samples were
analyzed by GC-MS with an HP5-MS column (60 m × 0.25 mm × 0.25 µm). The MS was calibrated
with perfluorotributylamine prior to each sequence. An alkane mixture with even carbon numbers
was measured before the biological analysis in order to obtain system-independent retention indices.
The system equilibration was performed by the injection of several pooled samples, which were
regularly monitored within the randomized sample sequences. The consistently found metabolites [29]
were identified by spectra and retention index matching to different libraries [30], including an in-house
database. To allow for a better comparability between the different cell lines, all metabolites were,
in addition to internal standard and peak sum normalization, normalized to the corresponding normal
glucose condition so as to obtain fold-changes. Statistical analyses were carried out by MetaboAnalyst
4.0 [31]. Analysis of variance (ANOVA) with the following FDR(false discovery rate)-adjustment was
carried out in order to determine significance (FDR-adjusted q-value of <0.05). The pairs of significance
were revealed by Tukey’s honestly significant difference (HSD) post-hoc test. The results of the latter
statistical analyses are depicted in Supplementary Table S2. For principal component analysis and heat
map generation, the values were range-scaled.
2.4. Data Availability
The data set of this study will be made publicly available in MetaboLights, under the study
identifier MTBLS1093 (https://www.ebi.ac.uk/metabolights/MTBLS1093).
3. Results and Discussion
To simulate diabetic complications in kidney cells in vitro, we applied three different glucose
concentrations (5, 11, and 30 mM) to undifferentiated and differentiated podocytes, which are the main
epithelial cells in the glomerulus and build up the slit diaphragm. Moreover, we applied two glucose
concentrations (5.5 and 25 mM) to two tubular cell lines (RPTECs/TERT1 and iRECs) and a collecting
duct cell line (mIMCD-3), in order to simulate hyperglycemia in this nephron compartment. As a
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consequence of the glomerular collapse and podocyte foot process effacement, a diffuse leak in the
glomerular filtration barrier occurs and serum proteins are excreted into the urine [32], where they
can impair tubular function. Microalbuminuria and albumin-induced tubulopathy are increasingly in
focus regarding the renal outcome and progression of DKD [33]. Therefore, we additionally exposed
all three tubular cell lines to elevated albumin concentrations. We applied an albumin concentration of
10 mg mL−1, which has already been used in other albumin overload experiments [34,35].
Untargeted GC-MS analyses revealed global metabolic changes in all of the cell lines analyzed.
For the podocytes, we used two growth conditions resulting in either undifferentiated or differentiated
podocytes. To focus on the specific impact of glucose on the metabolome, we normalized each condition
to the corresponding physiological glucose concentration (5 mM). In both podocyte cultures, a high
glucose administration led to 48.8% of total alterations, as documented by principal component (PC) 1
(Figure 1a).
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Figure 1. Principal component analysis (PCA) of different cell lines. (a) Glomerular cells showed global
metabolic alterations upon high glucose treatment. (b) Human proximal tubular cells revealed a global
alteration between the glucose concentrations, and further by the addition of albumin in the high
glucose condition. (c) Murine proximal tubular cells were discriminated by the glucose concentration.
(d) Murine collecting duct cells were separated by the glucose concentration, with further discrimination
by albumin addition in the high glucose condition. In each cellular system, that is, differentiated
podocytes, undifferentiate podocytes, RPTECs, in uced r nal epithelial tubular cells (iRECs), and
mIMCD-3 cells, the intensities were normalized to the corresponding physiological condition so as to
focus on the treatment specific effects (n = 4–8).
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Accordingly, in both of the differentiation states, two main metabolite clusters were observed
in the heat map, as follows: in podocytes grown in a highly concentrated glucose environment,
the intermediates of the polyol pathway were drastically increased, while amino acids and other
organic acids were decreased compared with normal and intermediate glucose levels (Figure 2a).
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Figure 2. Heat map and cluster analysis (Pearson/Ward) of the significantly altered (FDR corrected
q < 0.05) metabolites for the podocyte cell lines (a), for the proximal tubular cell lines RPTECs
(b), and iRECs (c), as well as for the collecting duct cell line mIMCD-3 (d). Range scaling was
performed to obtain the z-scores. “Fragment of Glc-NAc” is an indistinguishable fragment of either
N-acetylglucosamine-1-phosphate r N-acetylglucosamine-uridine diphosphate, with the first being
th direct precursor of the latter in the hexose amine pathway. The individual results and pairs of
significance obtained by Tuk y’s HSD are displayed in Supplementary Table S2. In each cellular
system (i.e., differentiated podocytes, undiffere tiated podocytes, RPTECs, iRECs, and mIMCD-3 cells),
the intensities were normalized to the corresponding physiological condition so as to focus on the
treatment specific effects. n = 4–8.
Correspondingly to podocytes, the samples were normalized to the associated physiological
condition (5 mM glucose without albumin stress) in RPTECs, iRECs, and mIMCD-3 cells. In all three
of the tubular cell lines, the differences in the glucose concentration had the most prominent effect on
the metabolome (Figure 1b–d). In RPTECs, these changes were represented by PC 1 with 62.1% of
alterations (Figure 1b). PC 2 accounted for 9.2% of alterations, and reflected the biological variance
(see Supplementary Figure S1). PC 3 revealed an impact of albumin overload, leading to 8.2% of
total alterations (Figure 1b). Importantly, a discrimination by albumin could only be observed under
high glucose conditions. In the RPTECs cultivated in physiological glucose conditions, the addition
of excess albumin did not lead to separate clustering in PC 3. In iRECs, the glucose concentration
accounted for 49.1% of total changes, and the metabolome was not affected globally by the albumin
overload (Figure 1c). In mIMCD-3 cells, the glucose concentration accounted for 43.3% (PC 1), and the
albumin treatment for 15.9% (PC 2) of total alterations. Analogously to RPTECs, global differences by
the addition of albumin could only be detected under high glucose concentrations in mIMCD-3 cells
(Figure 1d).
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A heat map analysis of the significantly altered metabolites (all of the statistical results in this
study are depicted in Supplementary Table S2) with corresponding cluster analysis (Pearson and
Ward) confirmed the results obtained by the principal component analyses (Figure 2). In the high
glucose condition of all of the nephron segments, including the collecting duct, most amino acids were
downregulated. The ketogenic and glucogenic amino acids were equally reduced. The downregulation
of amino acids is in accordance with the results of a GC-MS analysis conducted in the renal cortex
of Wistar rats [36]. In these animals, diabetes was induced by streptozotocin treatment, and the
diabetic kidneys showed a downregulation of most amino acids. Moreover, in a metabolomics study
analyzing the urinary excretion of metabolites in patients with diabetic kidney disease, amino acids,
fatty acids, and intermediates of the TCA cycle were reduced in the urine. According to the authors,
this downregulation of certain metabolites could be due to an impaired mitochondrial function and
reduced mitochondrial biogenesis [9]. In our data, branched-chain amino acids (BCAAs), like valine,
leucine, and isoleucine, were reduced in all of the analyzed cell lines (Figure 2). In streptozotocin-treated
rats, two weeks after the induction of diabetes, elevated levels of intermediates in the catabolism of
BCAAs could be detected [37]. On the other hand, there are studies that claim increased levels of
BCAAs in diabetic conditions [8]. Although data on the intracellular levels of BCAAs in diabetic
kidney disease are still inconsistent, there is an upregulation of plasma levels of branched-chain and
aromatic amino acids in diabetes. This upregulation can even be used as a predictor of future onset of
diabetes [38].
As expected, the concentration of glucose was drastically increased in the high glucose conditions
of all of the analyzed cell lines. Moreover, its direct downstream intermediates, including sorbitol
and fructose, were also significantly elevated (Figures 2 and 3), indicating an increased glucose
metabolization through the polyol pathway in podocytes (Figure 3a), proximal tubular cells (Figure 3b,c),
and collecting duct cells (Figure 3d). Interestingly, the addition of highly concentrated albumin led to
an additional significant boost of the polyol pathway intermediates in RPTECs (Figure 3b), whereas
glucose-6-phosphate was slightly reduced (Figure 2b). This suggests that the albumin uptake could
promote enhanced polyol pathway activation under high glucose concentrations. In the other proximal
tubular cell line (iRECs), the interplay of high glucose and albumin was necessary to gradually
increase fructose, while sorbitol was already elevated by the supraphysiological glucose concentrations
(Figure 3c). In mIMCD-3 cells, sorbitol and fructose were also increased by the addition of high glucose
levels (Figure 3d). However, in iRECs and mIMCD-3, we could not detect a significant additional
increase in the fructose concentration caused by albumin (Figure 3c,d).
In all of the cell lines, we observed a decrease of taurine and myo-inositol after applying high
glucose concentrations. In RPTECs, the addition of albumin further lowered the levels of taurine and
myo-inositol (Figure 2). A decrease of these two metabolites had already been linked to polyol pathway
activation [39], supporting our findings. Among others, these low molecular mass compounds serve as
intracellular osmolytes. They are correspondingly downregulated when the concentration of sorbitol
increases, in order to maintain osmotic pressure [39]. Moreover, taurine acts as an antioxidant and
counteracts the generation of reactive oxygen species (ROS) in diabetes [40].
Taken together, in all three nephron segments (i.e., glomerular, proximal tubular, and collecting
duct cells), the supraphysiological glucose levels led to a dramatic increase in sorbitol and fructose
concentrations. This effect was aggravated by albumin in RPTECs.
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Figure 3. Bar charts of the polyol pathway metabolites for the podocyte cell lines (a), for the proximal
tubular cell lines RPTECs (b), and iRECs (c), as well as for the collecting duct cell line mIMCD-3
(d). Fold changes to the normal glucose condition. Error bars indicate standard deviation. * p <0.05;
** p < 0.01; *** p < 0.001; n = 4–8.
In order to further validate our hypothesis of enhanced metabolization through the polyol
pathway under high glucose conditions, we tested the mRNA expression levels of aldo-keto
reductase a d sorbitol dehydrogenase in the tubular cell lines. Concordantly to the increased sorbitol
concentrations, the transcript level of aldo-keto reductase, the rate limi ing enzyme of the polyol
pathway, was significantly upregulated upon the addition f hig glucose in oth proximal tubular cell
lines, compared with normal glucose (Figure 4, upper and intermediate line). A further increase was
observed upon albumin overload in the high glucose condition in RPTECs (Figure 4, upper line), which
is in accordance to the additional increase in sorbitol levels. The next enzymatic step, mediated by
sorbitol dehydrogenase, was also significantly upregulated under hyperglycemic conditions in RPTECs.
Contrary to our expectations, the expression level of sorbitol dehydrogenase upon additional albumin
treatment i a high glucose oncentration was red ced to normoglycemic levels (Figure 4, upper line).
One possible explanation of this phenomenon could be a egativ feedback mechanism of increased
fructose concentrations on the sorbitol dehydrogenase expression. On the other hand, this inadequate
increase in the enzyme levels could further explain the sorbitol accumulation detected in RPTECs in a
high glucose and albumin concentration (Figure 3b). For quantitative RT-PCR in RPTECs, GAPDH
(glyceraldehyde-3-phosphate dehydrogenase), a known enzyme involved in glycolysis, was used as a
housekeeping gene in order to normalize the qPCR values. For internal control, heat shock 90kDa
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protein 1 beta (HSPCB) was also measured as a housekeeping gene. The expression levels of both
genes are not dependent on the glucose or albumin concentrations, as seen in Supplementary Figure S2.
In iRECs, high glucose concentrations led to elevated aldo- keto reductase levels, reflecting an elevated
sorbitol concentration. In accordance with our metabolomics data, this effect could not be further
enhanced by an albumin overload. The expression of sorbitol dehydrogenase, on the other hand, did
not show any dependence on the glucose and albumin levels in iRECs (Figure 4, intermediate line).
In mIMCD-3 cells, the mRNA expression levels of the aldo-keto reductase were not changed (Figure 4,
lower line). In general, sorbitol dehydrogenase was expressed at low levels in mIMCD-3 cells, and also
showed an opposing regulation upon treatment with glucose and albumin. Although the sorbitol and
fructose concentrations were elevated in mIMCD-3 cells, this could not be explained by an increase
in the transcription levels of the enzymes involved. This further supports the hypothesis that the
collecting duct reacts differently to diabetic stress conditions than proximal tubular cells (Figure 4).
In both nephron compartments, the expression of hexokinase-I was not increased upon diabetic stress
exposure (Supplementary Figure S3).
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Although the inhibition of aldo-keto reductase seems to be beneficial in diabetes [41], little is
known about the regulation of the transcript levels of aldo-keto reductase and sorbitol dehydrogenase
in diabetic kidney disease. In a study published in 2001, an upregulation of aldo-keto reductase and
sorbitol dehydrogenase mRNA could be detected in patients with diabetes and diabetic kidney disease,
depending on the glucose levels [42]. On the contrary, in diabetic neuropathy, the mRNA level is not
affected by the glucose levels [43].
Our data clearly support the hypothesis that the polyol pathway is activated in kidney cells
under diabetic conditions, and we speculate that the concentrations of metabolites and enzyme
transcription levels depend on the nephron segment analyzed. However, we cannot fully substantiate
this hypothesis, because the heterogeneity of the analyzed cellular systems regarding the species and
immortalization technique certainly biases this conclusion. Although it is a limitation of this study
that different metabolic responses detected along the nephron are in part caused by the heterogenic
origin of the cell lines, many metabolic alterations certainly arise from segment-specific physiological
behavior. The general activation of the polyol pathway and the associated decrease of taurine and
myo-inositol are robustly shown, occurring likewise in all cells.
4. Conclusions
In this study, we analyzed the impact of diabetic complications on different nephron segments
in murine and human cell models, covering the glomerulus, proximal tubule, and collecting duct.
We could detect a concomitant activation of the polyol pathway, especially an accumulation of sorbitol,
in each cell line tested. Importantly, we could show that the albumin stress further increased this
activation in the human proximal tubule. These results could be validated by a qPCR analysis of the
rate limiting enzyme in the polyol pathway, the aldo-keto reductase. Furthermore, global differences in
the metabolome were elucidated, covering amino acid metabolism and others. These results emphasize
the importance of including albumin as a diabetic stress factor for tubular cells when studying diabetic
kidney disease in in vitro models.
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